BILL 发表于 2025-3-25 04:12:44

http://reply.papertrans.cn/44/4305/430497/430497_21.png

olfction 发表于 2025-3-25 10:28:37

http://reply.papertrans.cn/44/4305/430497/430497_22.png

Stricture 发表于 2025-3-25 13:14:26

http://reply.papertrans.cn/44/4305/430497/430497_23.png

Subdue 发表于 2025-3-25 19:05:15

http://reply.papertrans.cn/44/4305/430497/430497_24.png

reception 发表于 2025-3-25 22:08:12

Book 2014ase. It brings together information from more than five decades of research and development on hydrophilic matrix tablets and provides perspective on contemporary issues. Twelve comprehensive chapters explore a variety of topics including polymers (hypromellose, natural polysaccharides and polyethyl

gorgeous 发表于 2025-3-26 00:58:20

http://reply.papertrans.cn/44/4305/430497/430497_26.png

cacophony 发表于 2025-3-26 05:21:45

http://reply.papertrans.cn/44/4305/430497/430497_27.png

maculated 发表于 2025-3-26 09:16:23

http://reply.papertrans.cn/44/4305/430497/430497_28.png

PALSY 发表于 2025-3-26 15:45:15

Applications of Polyethylene Oxide (POLYOX) in Hydrophilic Matrices,nd solubility combinations. Matrices can provide zero-order release profiles for soluble drugs. Long-term stability is aided by inclusion of an antioxidant and judicious choice of fillers at the formulation stage. Various formulation and processing studies are presented in this chapter using model formulation cases.

LIMN 发表于 2025-3-26 19:46:53

A Formulation Development Perspective on Critical Interactions Affecting the Performance of Hydrophibing these interactions to the extent that is possible from the presented literature. The formulation development scientist should apply these case studies when applicable to prudently assess risks and ensure the successful design of a robust controlled-release drug product.
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Hydrophilic Matrix Tablets for Oral Controlled Release; Peter Timmins,Samuel R. Pygall,Colin D. Melia Book 2014 American Association of Ph